2018 Fall Conference | C2 - Critical Care EEG Monitoring

Date Friday 10/26/18

Time 08:00 AM - 09:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Aatif M. Husain, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG), Neuro Trauma, Critical Care, and Sports Neurology

Learning Objectives Upon completion of this program, participants should be able to recognize appropriate patients who may benefit from cEEG monitoring; appreciate the nuanced interpretation of cEEG data and differentiate artifacts from seizures and other cerebral activity; and recognize the value and limitations of quantitative analysis of cEEG and apply this to their practice settings.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Academician, Resident, Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials

Event Timeline
08:00 AM - 08:05 AM	Introduction	Introduction Aatif M. Husain, MD
08:05 AM - 08:35 AM	Speaker	Critical Care EEG: Why, When and for Whom Aatif M. Husain, MD
08:35 AM - 09:00 AM	Speaker	EEG Patterns in the ICU Elizabeth Gerard, MD
09:00 AM - 09:25 AM	Speaker	Quantitative EEG: Uses and Limitations Frank W. Drislane, MD, FAAN
09:25 AM - 09:30 AM	Q&A	Questions and Answers Aatif M. Husain, MD

Faculty Disclosures
Aatif M. Husain, MD	Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for PranaQ. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceutical. Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Federation of Clinical Neurophysiology. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. The institution of Dr. Husain has received research support from PranaQ. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Frank W. Drislane, MD, FAAN	No disclosure on file
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��